How COVID-19 Testing Demand Threw off Thermo Fisher’s Acquisition of Qiagen

Value Creation in Molecular Diagnostics: A Game of Luck or Skill?

Demystifying SARS-CoV-2 Testing for COVID-19 (Third Edition – Part 1: Updates and Trends)

Demystifying SARS-CoV-2 Testing for COVID-19 (Second Edition)

Demystifying SARS-CoV-2 Testing for COVID-19 (First Edition)

How SARS-CoV-2 Will Catalyze Decentralized Testing

The Great Lockdown of 2020: Will the Life Sciences Emerge Unscathed?

US SARS-CoV-2 Testing Response: What can be learned from South Korea and Germany?

Health Advances Hosts 11th Annual Cocktail Reception at AACC – “The Clinical Lab of the Future”

What’s Next in Anterior Segment Ophthalmic Care: Highlights from the 2019 ASCRS Annual Meeting

Highlights from Health Advances Executive Panel – Precision Medicine: Oncology and Beyond

Liquid Biopsy: Tailwinds at Last

Danaher’s Massive Biopharma Acquisition: It’s the Fit that Counts

Specialty Lab versus Kit?

Join Health Advances at AACC for Our 10th Annual Cocktail Reception

OCTANe’s Annual OTS 2018 Fuels Excitement in Novel Technologies in Ophthalmology

Realizing the Power of Clinical and Consumer Genomics: Ethics, Business Models, and Regulatory Hurdles

Commercial and Developmental Innovation: What Can We Learn from Gene Therapies?

Genomics, will the cards stack up?

Highlights of the European Society for Medical Oncology (ESMO) Immuno-Oncology Congress

Health Advances Blog

Category: Diagnostics and Life Science Tools

How COVID-19 Testing Demand Threw off Thermo Fisher’s Acquisition of Qiagen

Value Creation in Molecular Diagnostics: A Game of Luck or Skill?

Demystifying SARS-CoV-2 Testing for COVID-19 (Third Edition – Part 1: Updates and Trends)

Demystifying SARS-CoV-2 Testing for COVID-19 (Second Edition)

Demystifying SARS-CoV-2 Testing for COVID-19 (First Edition)

How SARS-CoV-2 Will Catalyze Decentralized Testing

The Great Lockdown of 2020: Will the Life Sciences Emerge Unscathed?

US SARS-CoV-2 Testing Response: What can be learned from South Korea and Germany?

Health Advances Hosts 11th Annual Cocktail Reception at AACC – “The Clinical Lab of the Future”

What’s Next in Anterior Segment Ophthalmic Care: Highlights from the 2019 ASCRS Annual Meeting

Highlights from Health Advances Executive Panel – Precision Medicine: Oncology and Beyond

Liquid Biopsy: Tailwinds at Last

Danaher’s Massive Biopharma Acquisition: It’s the Fit that Counts

Specialty Lab versus Kit?

Join Health Advances at AACC for Our 10th Annual Cocktail Reception

OCTANe’s Annual OTS 2018 Fuels Excitement in Novel Technologies in Ophthalmology

Realizing the Power of Clinical and Consumer Genomics: Ethics, Business Models, and Regulatory Hurdles

Commercial and Developmental Innovation: What Can We Learn from Gene Therapies?

Genomics, will the cards stack up?

Highlights of the European Society for Medical Oncology (ESMO) Immuno-Oncology Congress